Found: 5
Select item for more details and to access through your institution.
Individual Vγ2-Jγ1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 6, p. 819, doi. 10.1007/s00262-006-0235-6
- By:
- Publication type:
- Article
S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells.
- Published in:
- Retrovirology, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1742-4690-10-122
- By:
- Publication type:
- Article
IBL4, A B cell line derived from an AIDS-related lymphoma, is a novel tumor stimulator and target for Vy2Vd2 T cell.
- Published in:
- Retrovirology, 2006, v. 3, p. P24, doi. 10.1186/1742-4690-3-S1-P24
- By:
- Publication type:
- Article
Rapid Activation of an Effector Phenotype in Human Vϒ2/Vσ2 T Cells Stimulated With a Toll-Like Receptor 2 (Tlr2) Agonist.
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Dynamic Shift from CD85j/ILT-2 to NKG2D NK Receptor Expression Pattern on Human Decidual NK during the First Trimester of Pregnancy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030017
- By:
- Publication type:
- Article